Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Breast Cancer (Tokyo, Japan)|October 13, 2011
Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancerPeifen Fu, Mutsuko Ibusuki, Yutaka Yamamoto, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2011
Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimensMutsuko Ibusuki, Peifen Fu, Satoko Yamamoto, et al.
International Journal of Oncology|March 5, 2015
Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancerAiko Sueta, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, et al.
CEN Case Reports|May 1, 2020
A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapyYasuo Kusunoki, Tomoko Namba-Hamano, Tsunayuki Kakimoto, et al.
Breast Cancer (Tokyo, Japan)|April 23, 2013
Divisional role of quantitative HER2 testing in breast cancerMutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Peifen Fu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2012
Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancerMutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Satoko Yamamoto, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
C6ORF97-ESR1 breast cancer susceptibility locus: influence on progression and survival in breast cancer patientsMutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Saori Fujiwara, et al.
Breast Cancer (Tokyo, Japan)|September 13, 2012
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein levelChunsen Xu, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, et al.
Pageof 4